Last updated on October 2017

Study of Local Administration of DepoTXA for Reduced Bleeding in Subjects Undergoing TKA


Brief description of study

This is a Phase 2, randomized, single-blind, active-controlled dose-ranging study in subjects scheduled to undergo total knee arthroplasty (TKA).

Detailed Study Description

Approximately 45 subjects (15 per arm) are planned for enrollment. Subjects will be randomized in a 1:1:1 ratio to receive either DepoTXA 800 mg, DepoTXA 1200 mg, or IV TXA (Cyklokapron® 1 gram).

Clinical Study Identifier: NCT02922582

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kelly Rooney

Ortho Arizona
Gilbert, AZ United States
  Connect »

Kelly Rooney

University of Miami Hospital
Miami, FL United States
  Connect »

Kelly Rooney

Kendall Regional Medical Center
Miami, FL United States
  Connect »

Kelly Rooney

Ohio State University/Wexner Medical Center
Columbus, OH United States
  Connect »

Kelly Rooney

Medical University of South Carolina
Charleston, SC United States
  Connect »